Accumulation of cholesterol in the liver leads to activation of liver X receptor α-sterol regulatory element-binding protein-1c (LXRα-SREBP-1c) pathway, which is the critical signaling cascade for the development of NAFLD [188]. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.